Over 10 years experience of Traceability Solutions

A smart and healthy approach to defending the bottom line
07 Sep

By pharmatrax

Category: Technoloy

A smart and healthy approach to defending the bottom line No Comments

A smart and healthy approach to defending the bottom line

New smart building technologies are helping pharmaceutical companies enhance productivity without compromising on compliance or quality. However, to maximise the available opportunities, companies need to…

Read More
Data man
14 Aug

By pharmatrax

Category: Technoloy

Industry’s adoption of natural language processing No Comments

Industry’s adoption of natural language processing

NLP in healthcare According to recent research, application of natural language processing (NLP) and text analytics in the healthcare and life sciences industries is forecast…

Read More
digital medicine
11 Aug

By pharmatrax

Category: News

Digital medication firm to launch in the UK in 2020 No Comments

Digital medication firm to launch in the UK in 2020

MedAdvisor, a digital medication management company, has announced it will launch in the UK market in early 2020, having secured its first UK pharmacy chain…

Read More
Network concept
11 Aug

By pharmatrax

Category: Technoloy

Data-driven care: why pharmacy needs to get involved No Comments

Data-driven care: why pharmacy needs to get involved

In the 20th century, oil was the commodity that made the world go around. In 2019, data is the new oil. In a similar way,…

Read More
Jubilant recalls contraceptives wrbm large
10 Aug

By pharmatrax

Category: News

Jubilant recalls lot of potentially ineffective contraceptives No Comments

Jubilant recalls lot of potentially ineffective contraceptives

Jubilant voluntarily recalls one lot of contraceptive tablets due to out-of-specification dissolution results, potentially decreasing efficacy. Jubilant Cadista Pharmaceuticals, a generics pharmaceutical company, announced the…

Read More
Drospirenone
03 Aug

By pharmatrax

Category: News

VOLUNTARY RECALL OF ETHINYL ESTRADIOL & DROSPIRENONE TABLETS, USP BY JUBILANT CADISTA PHARMACEUTICALS INC. BECAUSE OF OUT-OF-SPECIFICATION DISSOLUTION TEST RESULTS No Comments

VOLUNTARY RECALL OF ETHINYL ESTRADIOL & DROSPIRENONE TABLETS, USP BY JUBILANT CADISTA PHARMACEUTICALS INC. BECAUSE OF OUT-OF-SPECIFICATION DISSOLUTION TEST RESULTS

A batch of Ethinyl Estradiol & Drospirenone Tablets is recalled voluntarily by Jubilant Cadista Pharmaceuticals Inc. to the consumer level. The reason behind the recalling…

Read More
Collaboration is the key to innovation in pharma
01 Aug

By pharmatrax

Category: Technoloy

Collaboration is the key to innovation in pharma No Comments

Collaboration is the key to innovation in pharma

Enterprise Europe Network explains how collaboration is the key to innovation in pharma and how businesses should collaborate to grow. Successful business in the pharmaceutical industry depends…

Read More
value chain
31 Jul

By pharmatrax

Category: Technoloy

Pharma companies move up the value chain No Comments

Pharma companies move up the value chain

Firms ramping up innovation efforts in new sectors like high-quality drugs and biologics As China moves forward from being the world’s manufacturing powerhouse to an…

Read More
(NASDAQ:GOOG)
28 Jul

By pharmatrax

Category: Technoloy

Alphabet Inc. (NASDAQ:GOOG) managers are incubating vibrant new businesses in pharma and tech No Comments

Alphabet Inc. (NASDAQ:GOOG) managers are incubating vibrant new businesses in pharma and tech

Alphabet Inc. (NASDAQ:GOOG) managers are incubating vibrant new businesses in pharma and tech This might seem a particularly bad time to be investing in big…

Read More
Top Indian drugmakers expand in China as policy changes trigger opportunity
27 Jul

By pharmatrax

Category: News

Top Indian drugmakers expand in China as policy changes trigger opportunity No Comments

Top Indian drugmakers expand in China as policy changes trigger opportunity

China and India are both major API suppliers and generic-heavy countries. Because of the similarity, Indian drugmakers have long had a hard time finding an…

Read More